Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
Search for stocks (e.g., AAPL, GOOGL, AMZN)
XERS logo

XERS

NGS
Xeris Biopharma Holdings Inc.
HealthcareBiotechnology
Watchlists:
Last updated: Monday 14th July 2025
5.11
-0.16 (-3.04%)
Prev Close:5.27
Open:5.24
Bid:4.97
Ask:5.19
52 Week Range
2.10
6.07
Volume:2,127,067
Mkt Cap:764 M
Price Target
$5.88
+15.1%
Metrics

Growth

EPS
QoQ
N/A
YoY
N/A
Revenue
QoQ
N/A
YoY
N/A
Free Cash Flow
QoQ
N/A
YoY
N/A

Peers

Peers data not available
Available data keys: fn_01356, peerValues

Risk

Financial Health

Liquidity Ratios
Financial Scores

Technicals

Technical Oscillators
Volatility Metrics
Financials

Financial Statements

XERS - Income Statement (Annual)

Dec-24Dec-23Jun-23Mar-23Dec-22Invalid date
Depreciation And Amortization11 M11 M3 M11 M
General And Administrative Expense163 M146 M-709000.0138 M
Gross Profit Margin (profit Margin After CGS)166 M135 M33 M88 M
Interest Expense Non Operating27 M6 M14 M
Misc Other Special Charges8000.0-3 M537000.0
Net Income (loss)-55 M-62 M-17 M-95 M
Net Income Common Stockholders-55 M-62 M-17 M-95 M
Net Income Continuous Operations-55 M-62 M-17 M-95 M
Net Non Operating Interest Income Expense5 M5 M-5 M12 M
Non Recurring Operation Expense5 M
Normalized Income-31 M
Operating Income-34 M-44 M-8 M-82 M
Operating Income Before Depreciation (EBITDA)-41 M-48 M-14 M-9 M-68 M
Operating Expense237 M208 M41 M192 M
Other Gand A163 M146 M-709000.0138 M
Other Operating Expenses-61000.0-92000.0
Research Expense26 M22 M5 M21 M
Salaries And Wages18 M11 M12 M
Selling And Marketing Expense34 M
Selling Expense34 M
Total Income Available For Interest Expense (EBIT)-57 M-64 M-14 M-12 M-82 M
Total Revenues203 M164 M33 M110 M
Total Expenses274 M237 M62 M41 M215 M
Total Revenue203 M164 M33 M110 M
Amord11 M11 M3 M11 M
Avgshs147 M138 M137 M136 M
Avgshsdt147 M138 M137 M136 M
Basiceps-0.37-0.45-0.12-0.7
Basicepscont-0.37-0.45-0.7
Cor37 M29 M23 M
Depamor1 M2 M3 M11 M
Dileps-0.37-0.45-0.12-0.7
Dilepscont-0.37-0.45-0.7
Intinc5 M5 M1 M3 M
Netincdisc-55 M-62 M-17 M-95 M
Othincexp-4 M-2 M-1 M-3 M
Pretaxinc-57 M-37 M-17 M-96 M
Resdev26 M22 M5 M21 M
Sga163 M146 M34 M138 M
Shsout154 M140 M138 M137 M137 M
Specincchg-5 M
Taxprov-2 M-1 M-1 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement "your own" investment strategies in Excel with thousands of MarketXLS functions and templates.
MarketXLS provides all the tools I need for in-depth stock analysis. It's user-friendly and constantly improving. A must-have for serious investors.

John D.

Financial Analyst

I have been using MarketXLS for the last 6+ years and they really enhanced the product every year and now in the journey of bringing in AI...

Kirubakaran K.

Investment Professional

MarketXLS is a powerful tool for financial modeling. It integrates seamlessly with Excel and provides real-time data.

David L.

Financial Analyst

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel.

Lloyd L.

Professional Trader